Reference health

Caffeine: an evaluation of the safety database

https://doi.org/10.1016/b978-0-12-821038-3.00032-x
CiteStamped reference-health badge
72/72 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

19 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 72 checked references that resolve
resolves10.1016/j.yrtph.2016.07.011
The acute lethal dose 50 (LD50) of caffeine in albino rats
resolves10.1007/978-3-642-13443-2_3
Pharmacokinetics and Metabolism of Natural Methylxanthines in Animal and Man
resolves10.1097/PEC.0b013e31821dc72b
First-Onset Seizure After Use of 5-hour ENERGY
resolves10.1080/10408440500534362
The Acquisition and Application of Absorption, Distribution, Metabolism, and Excretion (ADME) Data in Agricultural Chemical Safety Assessments
resolves10.1007/BF00613933
The absolute bioavailability of caffeine in man
resolves10.1007/978-3-642-13443-2_9
Methylxanthines, Seizures, and Excitotoxicity
resolves10.1038/clpt.1982.132
Caffeine disposition after oral doses
resolves10.3109/03602538409029964
Interspecies Comparison of In Vivo Caffeine Pharmacokinetics in Man, Monkey, Rabbit, Rat and Mouse
resolves10.1542/peds.2013-2877
Trends in Caffeine Intake Among US Children and Adolescents
resolves10.1159/000457332
Pharmacokinetics of Caffeine during and after Pregnancy
resolves10.1002/bdrb.20288
Evaluation of the reproductive and developmental risks of caffeine
resolves10.1089/jcr.2013.0005
Caffeine Withdrawal and Dependence: A Convenience Survey Among Addiction Professionals
resolves10.3109/03602537508993756
Physiological Disposition of Caffeine
resolves10.4236/pp.2014.54054
Population Pharmacokinetic Pharmacodynamic Modeling of Caffeine Using Visual Analogue Scales
resolves10.1016/S0090-9556(25)07906-1
Human metabolism of [1-methyl-14C]- and [2-14C]caffeine after oral administration.
resolves10.1590/S0066-782X2000000800002
Influence of caffeine on blood pressure and platelet aggregation
resolves10.1155/2018/9061234
Efficacy and Safety of Different Maintenance Doses of Caffeine Citrate for Treatment of Apnea in Premature Infants: A Systematic Review and Meta-Analysis
resolves10.1002/tera.1047
Teratogen update: Evaluation of the reproductive and developmental risks of caffeine
resolves10.1016/S1734-1140(11)70394-2
Caffeine and the anticonvulsant potency of antiepileptic drugs: experimental and clinical data
resolves10.1016/0278-6915(87)90098-6
Potential reversibility of skeletal effects in rats exposed in utero to caffeine
resolves10.3945/ajcn.2010.29627
Caffeine consumption and incident atrial fibrillation in women
resolves10.1136/bmj.313.7069.1358
Relation of caffeine intake and blood caffeine concentrations during pregnancy to fetal growth: prospective population based study
resolves10.1161/01.CIR.0000046228.97025.3A
Coffee Acutely Increases Sympathetic Nerve Activity and Blood Pressure Independently of Caffeine Content
resolves10.1111/j.1528-1157.1990.tb05382.x
Influence of Different Methylxanthines on the Anticonvulsant Action of Common Antiepileptic Drugs in Mice
resolves10.1016/0300-9432(74)90056-9
Lethal caffeine poisoning in a child
resolves10.3390/nu8030154
Sources of Caffeine in Diets of US Children and Adults: Trends by Beverage Type and Purchase Location
resolves10.1111/j.1528-1167.2009.02268.x
A prospective study of smoking, caffeine, and alcohol as risk factors for seizures or epilepsy in young adult women: Data from the Nurses’ Health Study II
resolves10.1592/phco.20.7.644.35167
Caffeine Citrate for the Treatment of Apnea of Prematurity: A Double‐Blind, Placebo‐Controlled Study
resolves10.3945/ajcn.113.080077
Trends in intake and sources of caffeine in the diets of US adults: 2001–2010
resolves10.1253/circj.CJ-10-0820
Diet and Risk of Atrial Fibrillation - Epidemiologic and Clinical Evidence -
resolves10.1146/annurev-nutr-071816-064941
Coffee, Caffeine, and Health Outcomes: An Umbrella Review
resolves10.1111/j.1750-3841.2010.01561.x
Caffeine (1, 3, 7‐trimethylxanthine) in Foods: A Comprehensive Review on Consumption, Functionality, Safety, and Regulatory Matters
resolves10.1093/aje/kws222
Coffee, Tea, and Fatal Oral/Pharyngeal Cancer in a Large Prospective US Cohort
resolves10.1371/journal.pone.0059561
The Metabolic and Performance Effects of Caffeine Compared to Coffee during Endurance Exercise
resolves10.1038/nn1491
Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine
resolves10.1016/0167-8760(90)90031-8
The influence of user status and anxious disposition on the hypertensive effects of caffeine
resolves10.1016/j.ygyno.2013.03.014
Coffee and caffeine intake and breast cancer risk: An updated dose–response meta-analysis of 37 published studies
resolves10.1093/jat/bkx011
Review of Caffeine-Related Fatalities along with Postmortem Blood Concentrations in 51 Poisoning Deaths
resolves10.3945/ajcn.112.038794
Associations between polymorphisms in the AHR and CYP1A1-CYP1A2 gene regions and habitual caffeine consumption
resolves10.1111/bcp.13089
Systematic review and meta‐analysis of clinical outcomes of early caffeine therapy in preterm neonates
resolves10.1111/j.1745-4565.1982.tb00435.x
THE PHARMACOLOGY AND TOXICOLOGY OF CAFFEINE
resolves10.1523/JNEUROSCI.6730-10.2011
Arousal Effect of Caffeine Depends on Adenosine A2A Receptors in the Shell of the Nucleus Accumbens
resolves10.1001/jamainternmed.2018.2425
Association of Coffee Drinking With Mortality by Genetic Variation in Caffeine Metabolism
resolves10.3945/an.114.006692
Institute of Medicine. 2014. Caffeine in Food and Dietary Supplements: Examining Safety—Workshop Summary. Washington, DC: The National Academies Press, 2014
resolves10.1016/j.fct.2013.10.042
Beverage caffeine intakes in the U.S.
resolves10.1016/0278-6915(84)90367-3
The influence of caffeine on tunour indicidence in Sprague-Dawley rats
resolves10.1016/0002-9149(87)90842-3
Caffeine as a possible cause of ventricular arrhythmias during the healing phase of acute myocardial infarction
resolves10.1093/ajh/4.5.427
The Effect of Caffeine on Daytime Ambulatory Blood Pressure
resolves10.1080/0265203021000007840
Effects of caffeine on human health
resolves10.1007/BF00609587
Plasma and salivary pharmacokinetics of caffeine in man
resolves10.1016/j.canlet.2008.08.022
Coffee consumption and the risk of cancer: An overview
resolves10.1097/01.hjh.0000166828.94699.1d
Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials
resolves10.1016/j.fct.2010.06.019
A review of the epidemiologic evidence concerning the reproductive health effects of caffeine consumption: A 2000–2009 update
resolves10.1016/j.amjmed.2010.10.017
Caffeine and Cardiac Arrhythmias: A Review of the Evidence
resolves10.1016/j.lfs.2014.01.083
Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: A review
resolves10.1172/JCI110124
Tolerance to the humoral and hemodynamic effects of caffeine in man.
resolves10.1016/j.foodres.2019.05.029
Drinking for protection? Epidemiological and experimental evidence on the beneficial effects of coffee or major coffee compounds against gastrointestinal and liver carcinogenesis
resolves10.2165/00003495-199549010-00004
Pharmacological Rationale for the Clinical Use of Caffeine
resolves10.1001/jama.2011.2024
Survival Without Disability to Age 5 Years After Neonatal Caffeine Therapy for Apnea of Prematurity
resolves10.1056/NEJMoa054065
Caffeine Therapy for Apnea of Prematurity
resolves10.1056/NEJMoa073679
Long-Term Effects of Caffeine Therapy for Apnea of Prematurity
resolves10.1378/chest.87.3.319
The Effect of Caffeine on Cardiac Rate, Rhythm, and Ventricular Repolarization
resolves10.1016/S0022-3565(25)33447-6
Disposition of caffeine and its metabolites in man.
resolves10.3109/10408448209037495
The toxicology of cocoa and methylxanthines: A review of the literature
resolves10.1037/a0021651
Effects of acute caffeine administration on adolescents.
resolves10.1016/j.fct.2016.06.007
Trends and patterns of caffeine consumption among US teenagers and young adults, NHANES 2003–2012
resolves10.1016/j.amepre.2018.12.007
Trends in Energy Drink Consumption Among U.S. Adolescents and Adults, 2003–2016
resolves10.3109/15563650.2016.1146740
Pharmacokinetic analysis and comparison of caffeine administered rapidly or slowly in coffee chilled or hot versus chilled energy drink in healthy young adults
resolves10.1016/j.fct.2017.04.002
Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children
resolves10.1016/S0015-6264(77)80199-5
A 2-year feeding study of instant. Coffees in rats. II. Incidence and types of neoplasms
resolves10.1016/S0015-6264(77)80256-3
A 2-year feeding study of instant coffees in rats. I. Body weight, food consumption, haematological parameters and plasma chemistry
The 19 references without a DOI — listed, not checked
no DOI — not checkedCaffeine intake and atrial fibrillation incidence: dose response meta-analysis of prospective cohort studies
no DOI — not checkedDietitians of Canada. 2014. Food sources of caffeine. Available: http://www.dietitians.ca/Your-Health/Nutrition-A-Z/Caffeine/Food-Sources-of-Caffeine.aspx [accessed 06/03/2015].
no DOI — not checkedDo energy drinks cause epileptic seizure and ischemic stroke?
no DOI — not checkedScientific opinion on the safety of caffeine
no DOI — not checkedApnea of prematurity: caffeine dose optimization
no DOI — not checkedIARC (1991). Caffeine. In: Coffee, Tea, Mate, Methylxanthines and Methylglyoxal. IARC Working Group, Feb. 27-Mar. 6, 1990, Lyon, France. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 51). World Health Organization (WHO), Lyon, France: International Agency for Research on Cancer (IARC), pp. 291-390.
no DOI — not checkedIARC (2018). Drinking Coffee, Mate, and Very Hot Beverages. Expert Opinions of IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, May 24-31, 2016, Lyon, France. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 116). Lyon, France: International Agency for Research on Cancer (IARC).
no DOI — not checkedCaffeine for the sustainment of mental task performance: fomulations for military operations
no DOI — not checkedIPCS. 1998. Caffeine.
no DOI — not checkedThe relationship between tea and coffee consumption and glioma: a systematic review
no DOI — not checked10.1016/B978-0-12-821038-3.00032-X_bib60
no DOI — not checkedOECD-SIDS. 2002. Organisation for economic co-operation and development screening information dataset (OECD SIDS). Initial assessment profile: Caffeine. Available at www.chemunepch/irptc/sids/OECDSIDS/CAFFEINE.pdf.
no DOI — not checkedSCF (Scientific Committee on Food), 1999. Opinion on Caffeine, Taurine and D-Glucurono -γ-Lactone as constituents of so-called “energy” drinks. 15 pp.
no DOI — not checkedCaffeinated energy drink intoxication
no DOI — not checkedUS FDA (2018a). FDA Warns Companies to Stop Selling Dangerous and Illegal Pure and Highly Concentrated Caffeine Products. Silver Spring (MD): U.S. Food and Drug Administration (U.S. FDA).
no DOI — not checkedPart 340—Stimulant drug products for over-the-counter human use. §340.50—Labeling of stimulant drug products
no DOI — not checkedUS FDA, 2012 FDA, 2012. Letter from Jeanne Ireland, Assistant Commissioner for Legislation to the Honorable Richard J. Durbin, Senator dated August 10, 2012 [Re: Letter of April 3, 2012 Expressing Concern About Potential Safety Issues Associated With the Consumption of so-called “Energy Drinks”]. Available from: http://www.durbin.senate.gov/imo/media/doc/09112012FDA.pdf.
no DOI — not checkedUS FDA, 21 CFR 340.50. Part 340—stimulant drug products for over-the-counter human use. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=340.50.
no DOI — not checkedUS FDA, Oakridge National Laboratory. 2010. Caffeine intake by the U.S population.
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1016/b978-0-12-821038-3.00032-x"><img src="https://citestamp.com/citestamped/10.1016/b978-0-12-821038-3.00032-x/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1016/b978-0-12-821038-3.00032-x/badge.svg)](https://citestamp.com/citestamped/10.1016/b978-0-12-821038-3.00032-x)